Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Vitiello

Showing results (71-80 of 88) with videos related to

Pageof 9
Sort By:
Archives of Neurology|January 27, 1998
Randomized double-blind placebo-controlled trial of peptide T for HIV-associated cognitive impairmentP N Heseltine, K Goodkin, J H Atkinson, et al.
The Pharmacogenomics Journal|July 17, 2013
Positive effects of methylphenidate on hyperactivity are moderated by monoaminergic gene variants in children with autism spectrum disordersJ T McCracken, K K Badashova, D J Posey, et al.
Archives of General Psychiatry|September 6, 2001
Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United StatesE G Bing, M A Burnam, D Longshore, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|February 24, 2001
Methylphenidate dosage for children with ADHD over time under controlled conditions: lessons from the MTAB Vitiello, J B Severe, L L Greenhill, et al.
Journal of Child and Adolescent Psychopharmacology|February 13, 2002
Methodological issues in designing a multisite trial of risperidone in children and adolescents with autismL Scahill, J McCracken, C J McDougle, et al.
Journal of Developmental and Behavioral Pediatrics : JDBP|March 27, 2001
Findings from the NIMH Multimodal Treatment Study of ADHD (MTA): implications and applications for primary care providersP S Jensen, S P Hinshaw, J M Swanson, et al.
Translational Psychiatry|June 27, 2013
Moderation of antipsychotic-induced weight gain by energy balance gene variants in the RUPP autism network risperidone studiesE L Nurmi, S L Spilman, F Whelan, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|October 1, 1996
Medication treatment strategies in the MTA Study: relevance to clinicians and researchersL L Greenhill, H B Abikoff, L E Arnold, et al.
Child and Adolescent Psychiatric Clinics of North America|February 16, 2000
Research Units on Pediatric Psychopharmacology (RUPP) Autism Network. Background and rationale for an initial controlled study of risperidoneC J McDougle, L Scahill, J T McCracken, et al.
Journal of Abnormal Child Psychology|December 5, 2000
Anxiety as a predictor and outcome variable in the multimodal treatment study of children with ADHD (MTA)J S March, J M Swanson, L E Arnold, et al.
Pageof 9

Showing results (71-80 of 88) with videos related to

Sort By:
Pageof 9
Archives of Neurology|January 27, 1998
Randomized double-blind placebo-controlled trial of peptide T for HIV-associated cognitive impairmentP N Heseltine, K Goodkin, J H Atkinson, et al.
The Pharmacogenomics Journal|July 17, 2013
Positive effects of methylphenidate on hyperactivity are moderated by monoaminergic gene variants in children with autism spectrum disordersJ T McCracken, K K Badashova, D J Posey, et al.
Archives of General Psychiatry|September 6, 2001
Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United StatesE G Bing, M A Burnam, D Longshore, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|February 24, 2001
Methylphenidate dosage for children with ADHD over time under controlled conditions: lessons from the MTAB Vitiello, J B Severe, L L Greenhill, et al.
Journal of Child and Adolescent Psychopharmacology|February 13, 2002
Methodological issues in designing a multisite trial of risperidone in children and adolescents with autismL Scahill, J McCracken, C J McDougle, et al.
Journal of Developmental and Behavioral Pediatrics : JDBP|March 27, 2001
Findings from the NIMH Multimodal Treatment Study of ADHD (MTA): implications and applications for primary care providersP S Jensen, S P Hinshaw, J M Swanson, et al.
Translational Psychiatry|June 27, 2013
Moderation of antipsychotic-induced weight gain by energy balance gene variants in the RUPP autism network risperidone studiesE L Nurmi, S L Spilman, F Whelan, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|October 1, 1996
Medication treatment strategies in the MTA Study: relevance to clinicians and researchersL L Greenhill, H B Abikoff, L E Arnold, et al.
Child and Adolescent Psychiatric Clinics of North America|February 16, 2000
Research Units on Pediatric Psychopharmacology (RUPP) Autism Network. Background and rationale for an initial controlled study of risperidoneC J McDougle, L Scahill, J T McCracken, et al.
Journal of Abnormal Child Psychology|December 5, 2000
Anxiety as a predictor and outcome variable in the multimodal treatment study of children with ADHD (MTA)J S March, J M Swanson, L E Arnold, et al.
Pageof 9